N-[5-(5-Fluoropyridin-3-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutyramide (SEN78702, WYE-308775): A Medicinal Chemistry Effort toward an α7 Nicotinic Acetylcholine Receptor Agonist Preclinical Candidate

被引：15

作者：

Zanaletti, Riccardo ^{[1
]}

Bettinetti, Laura ^{[1
]}

Castaldo, Cristiana ^{[1
]}

Ceccarelli, Ilaria ^{[1
]}

Cocconcelli, Giuseppe ^{[1
]}

Comery, Thomas A. ^{[2
]}

Dunlop, John ^{[2
]}

Genesio, Eva ^{[1
]}

Ghiron, Chiara ^{[1
]}

Haydar, Simon N. ^{[2
]}

Jow, Flora ^{[2
]}

Maccari, Laura ^{[1
]}

Micco, Iolanda ^{[1
]}

Nencini, Arianna ^{[1
]}

Fratelli, Carmela ^{[1
]}

Scali, Carla ^{[1
]}

Turlizzi, Elisa ^{[1
]}

Valacchi, Michela ^{[1
]}

机构：

[1] Siena Biotech SpA, I-53100 Siena, Italy

[2] Pfizer Inc, Neurosci Res Unit, Groton, CT 06340 USA

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2012年 / 55卷 / 22期

关键词：

DISCOVERY; SCHIZOPHRENIA; RAT;

D O I：

10.1021/jm3013568

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

alpha 7 nicotinic acetylcholine receptors (alpha 7 nAChR) represent promising therapeutic candidates for the treatment of cognitive impairment, associated with Alzheimer's disease (AD) and schizophrenia. A medicinal chemistry effort around previously reported compound 1 (SEN15924, WAY 361789) led to the identification of 12 (SEN78702, WYE-308775) a potent and selective full agonist of the alpha 7 nAChR that demonstrated improved plasma stability, brain levels, and efficacy in behavioral cognition models.

引用

页码：10277 / 10281

页数：5

共 10 条

[1] Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789)
Zanaletti, Riccardo
Bettinetti, Laura
Castaldo, Cristiana
Cocconcelli, Giuseppe
Comery, Thomas
Dunlop, John
Gaviraghi, Giovanni
Ghiron, Chiara
Haydar, Simon N.
Jow, Flora
Maccari, Laura
Micco, Iolanda
Nencini, Arianna
Scali, Carla
Turlizzi, Elisa
Valacchit, Michela
JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (10) : 4806 - 4823
[2] Discovery and SAR of N-(1-((substituted piperidin-4-yl)methyl)-3-methoxypiperidin-4-yl)-2-methoxybenzamide derivatives: 5-Hydroxytryptamine receptor 4 agonist as a potent prokinetic agent
Park, Jung Sang
Im, Weonbin
Choi, Sunghak
Park, Sook Jin
Jung, Jun Min
Baek, Ki Seon
Son, Han Pyo
Sharma, Satyasheel
Kim, In Su
Jung, Young Hoon
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 109 : 75 - 88
[3] Discovery of 4-(5-(4-Chlorophenyl)-2-methyl-3-propionyl-1H-pyrrol-1-yl)benzenesulfonamide (A-867744) as a Novel Positive Allosteric Modulator of the α7 Nicotinic Acetylcholine Receptor
Faghih, Ramin
Gopalakrishnan, Sujatha M.
Gronlien, Jens Halvard
Malysz, John
Briggs, Clark A.
Wetterstrand, Caroline
Ween, Hilde
Curtis, Michael P.
Sarris, Kathy A.
Gfesser, Gregory A.
El-Kouhen, Rachid
Robb, Holly M.
Radek, Richard J.
Marsh, Kennan C.
Bunnelle, William H.
Gopalakrishnan, Murali
JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (10) : 3377 - 3384
[4] Discovery of N-[(3R,5R)-1-azabicyclo[3.2.1]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide as an agonist of the α7 nicotinic acetylcholine receptor:: In vitro and in vivo activity
Acker, Brad A.
Jacobsen, E. Jon
Rogers, Bruce N.
Wishka, Donn G.
Reitz, Steven C.
Piotrowski, David W.
Myers, Jason K.
Wolfe, Mark L.
Groppi, Vincent E.
Thornburgh, Bruce A.
Tinholt, Paula M.
Walters, Rodney R.
Olson, Barbara A.
Fitzgerald, Laura
Staton, Brian A.
Raub, Thomas J.
Krause, Michael
Li, Kai S.
Hoffmann, William E.
Hajos, Mihaly
Hurst, Raymond S.
Walker, Daniel P.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (12) : 3611 - 3615
[5] Pharmacological and behavioral profile of N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]-6-chinolincarboxamide (EVP-5141), a novel α7 nicotinic acetylcholine receptor agonist/serotonin 5-HT3 receptor antagonist
Boess, Frank G.
de Vry, Jean
Erb, Christina
Flessner, Timo
Hendrix, Martin
Luithle, Joachim
Methfessel, Christoph
Schnizler, Katrin
van der Staay, F. Josef
van Kampen, Marja
Wiese, Welf-Burkhard
Koenig, Gerhard
PSYCHOPHARMACOLOGY, 2013, 227 (01) : 1 - 17
[6] Synthesis of Substituted -N-(5-((7-Methyl-2-Oxo-2H-Chromen-4-yl)-Methyl)-1,3,4-Thiadiazol-2-yl)-Benzamide Derivatives Using TBTU as Coupling Agent and their Evaluation for Anti Tubercular Activity
Kakadiya, Monika
Pasha, Yunus
Noolvi, Malleshappa
Patel, Ashish
LETTERS IN ORGANIC CHEMISTRY, 2022, 19 (02) : 158 - 166
[7] In Vitro Pharmacological Characterization of a Novel Allosteric Modulator of α7 Neuronal Acetylcholine Receptor, 4-(5-(4-Chlorophenyl)-2-methyl-3-propionyl-1H-pyrrol-1-yl)benzenesulfonamide (A-867744), Exhibiting Unique Pharmacological Profile
Malysz, John
Gronlien, Jens Halvard
Anderson, David J.
Hakerud, Monika
Thorin-Hagene, Kirsten
Ween, Hilde
Wetterstrand, Caroline
Briggs, Clark A.
Faghih, Ramin
Bunnelle, William H.
Gopalakrishnan, Murali
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 330 (01) : 257 - 267
[8] Development and Evaluation in Rat and Monkey of a Candidate Homochiral Radioligand for PET Studies of Brain Receptor Interacting Protein Kinase 1: [18F](S)-1-(5-(3-Fluorophenyl)-4,5-dihydro-1H-pyrazol-1-yl)-2,2-dimethylpropan-1-one
Jana, Susovan
Maqbool, Mudasir
Yan, Xuefeng
Jakobsson, Jimmy E.
Lee, Adrian C.
Liow, Jeih-San
Zoghbi, Sami S.
Wu, Shawn
Long, Priscilla
Innis, Robert B.
Telu, Sanjay
Pike, Victor W.
ACS CHEMICAL NEUROSCIENCE, 2025, 16 (02): : 203 - 222
[9] Improving the Pharmacokinetic and CYP Inhibition Profiles of Azaxanthene-Based Glucocorticoid Receptor Modulators-Identification of (S)-5-(2-(9-Fluoro-2-(4-(2-hydroxypropan-2-yl)phenyl)-5H-chromeno[2,3-b]pyridin-5-yl)-2-methylpropanamido)-N-(tetrahydro-2H-pyran-4-yl)-1,3,4-thiadiazole-2-carboxamide (BMS-341)
Yang, Michael G.
Dhar, T. G. Murali
Xiao, Zili
Xiao, Hai-Yun
Duan, James J. -W.
Jiang, Bin
Galella, Michael A.
Cunningham, Mark
Wang, Jinhong
Habte, Sium
Shuster, David
McIntyre, Kim W.
Carman, Julie
Holloway, Deborah A.
Somerville, John E.
Nadler, Steven G.
Salter-Cid, Luisa
Barrish, Joel C.
Weinstein, David S.
JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (10) : 4278 - 4290
[10] Optimization of Potent, Selective, and Orally Bioavailable Pyrrolodinopyrimidine-Containing Inhibitors of Heat Shock Protein 90. Identification of Development Candidate 2-Amino-4-{4-chloro-2-[2-(4-fluoro-1H-pyrazol-1-yl)ethoxy]-6-methylphenyl}-N-(2,2-difluoropropyl)-5,7-dihydro-6H-pyrrolo [3,4-d]pyrimidine-6-carboxamide
Zehnder, Luke
Bennett, Michael
Meng, Jerry
Huang, Buwen
Ninkovic, Sacha
Wang, Fen
Braganza, John
Tatlock, John
Jewell, Tanya
Zhou, Joe Zhongxiang
Burke, Ben
Wang, Jeff
Maegley, Karen
Mehta, Pramod P.
Yin, Min-Jean
Gajiwala, Ketan S.
Hickey, Michael J.
Yamazaki, Shinji
Smith, Evan
Kang, Ping
Sistla, Anand
Dovalsantos, Elena
Gehring, Michael R.
Kania, Robert
Wythes, Martin
Kung, Pei-Pei
JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (09) : 3368 - 3385

← 1 →